Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an
Eduardo Ramacciotti1, Angela E Hawley, Diana M Farris
1Conrad Jobst Vascular Research Laboratories, Section of Vascular Surgery, University of Michigan Medical School Center, Ann Arbor, MI, USA. erama@med.umich.edu
Abstract:
Microparticles (MP) are lipid vesicles from platelets, leukocytes and endothelial cells that are involved in early thrombogenesis. We evaluated a detailed time-course analysis of MPs on thrombogenesis and the associated tissue factor (TF) activity in wild-type, in gene-deleted for E- and P-selectins and with high levels of P-selectin expression after the initiation of venous thrombosis in mice. Inferior vena cava (IVC) ligation was performed on C57BL/6 mice (n = 191, 59 = wild-type [WT], 55 = gene-deleted for E- and P - selectins [knock-outs, EPKO] and 77 = elevated levels of soluble P-selectin, named Delta Cytoplasmic Tail (DeltaCT). Animals were euthanised at various time points to assess MP production, origin and thrombus weight. MPs were re-injected into separate mice at concentrations of 80,000 and 160,000 units, as well as from different ages. In addition, MPs from thrombosed animals were pooled and TF activity quantitated using a chromogenic assay. Thrombus weight correlated negatively with MPs derived from leukocytes, and positively with MPs derived from platelets for WT animals (p < 0.05), while MPs from platelets presented a positive correlation to thrombus weight in the WT and EPKO groups (p < 0.01). Total MPs correlated negatively with thrombus weight in the DeltaCT group (p < 0.05). MP re-injections led to greater thrombus weight, while older MP reinjections tended to form larger thrombus than younger. Finally, TF bearing MPs showed a significant correlation to MP concentrations (R = 0.99). In conclusion, MPs appear to be an important element in venous thrombogenesis.
Insights
Microparticles (MPs) are key players in blood clot formation. This study shows MPs from platelets increase clot size, while those from leukocytes decrease it, highlighting their complex role in thrombogenesis.
Area of Science:
- Hematology
- Vascular Biology
- Biochemistry
Background:
- Microparticles (MPs) are lipid vesicles released from activated cells, including platelets, leukocytes, and endothelial cells.
- MPs play a critical role in hemostasis and thrombosis, particularly in the early stages of clot formation.
- Tissue Factor (TF) expressed on MPs is a potent initiator of the coagulation cascade.
Purpose of the Study:
- To investigate the detailed time-course of microparticle production and their impact on venous thrombogenesis.
- To analyze the association between microparticle origin (platelet, leukocyte, endothelial) and thrombus weight.
- To evaluate the role of Tissue Factor (TF) activity on microparticles in the context of thrombosis.
Main Methods:
- Venous thrombosis was induced in mice (wild-type, E/P-selectin knock-outs, and elevated soluble P-selectin) via inferior vena cava (IVC) ligation.
- Microparticle levels, origin, and TF activity were assessed at various time points post-ligation.
- Microparticles were re-injected into recipient mice to determine their direct effect on thrombus formation.
Main Results:
- Thrombus weight positively correlated with platelet-derived MPs and negatively with leukocyte-derived MPs in wild-type mice.
- Platelet-derived MPs showed a positive correlation with thrombus weight in both wild-type and E/P-selectin knock-out mice.
- Re-injection of MPs, particularly older ones, increased thrombus weight, and TF-bearing MPs strongly correlated with MP concentration.
Conclusions:
- Microparticles are significant contributors to venous thrombogenesis.
- The cellular origin of microparticles influences their pro-thrombotic or anti-thrombotic potential.
- TF-bearing microparticles are directly linked to increased clot formation, underscoring their clinical relevance.
Related Concept Videos
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins


